CRY1 Gene

CRY1 Gene

Introduction

Cry1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

CRY1 Gene

Introduction

Cry1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@lowrey2011]
<table> [@partch2014]
<tr><th colspan="2" style="background-color: #4a90d9; color: white;">CRY1 (Cryptochrome Circadian Regulator 1)</th></tr> [@sulli2019]
<tr><td><strong>Official Symbol</strong></td><td>CRY1</td></tr> [@musiek2016]
<tr><td><strong>Full Name</strong></td><td>Cryptochrome Circadian Regulator 1</td></tr> [@van2015]
<tr><td><strong>Chromosomal Location</strong></td><td>12q24.31</td></tr> [@zhang2016]
<tr><td><strong>NCBI Gene ID</strong></td><td>1399</td></tr> [@patke2017]
<tr><td><strong>OMIM</strong></td><td>601033</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000012048</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q9UQL6</td></tr>
<tr><td><strong>Protein</strong></td><td>CRY1 protein (approx. 66 kDa)</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous (high in brain, liver, retina)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">173 edges</a></td>
</tr>
</table>
</div>

Overview

The CRY1 gene encodes Cryptochrome Circadian Regulator 1, a flavin adenine dinucleotide (FAD)-binding protein that serves as a critical negative feedback component in the mammalian circadian clock. CRY1 functions as an intrinsic photoreceptor and transcriptional repressor that stabilizes circadian rhythms with approximately 24-hour periodicity.

Normal Function

Circadian Rhythm Regulation

CRY1 is essential for the negative feedback loop of the molecular circadian clock:

Molecular Properties

• Photoreception: CRY1 detects blue light (~450 nm) through its FAD cofactor
• Intrinsic Photoreceptor: Mediates circadian photoentrainment in mammals
• Clock Period: CRY1 is essential for maintaining circadian period length
• Temperature Compensation: Functions across physiological temperature ranges

Metabolic Regulation

CRY1 controls expression of metabolic genes:

• Regulates hepatic glucose metabolism
• Modulates lipid metabolism
• Controls cholesterol biosynthesis
• Influences mitochondrial function

Protein Structure

Domains

• Photolyase Homology Region (PHR): N-terminal domain (~500 aa) binding FAD
• C-terminal Tail (CCT): Regulates protein interactions and stability
• DASSS Motif: Phosphorylation sites regulating degradation

Post-translational Modifications

• Phosphorylation: By CK1d/e at multiple serine/threonine residues
• Ubiquitination: By FBXL3 leading to proteasomal degradation
• Acetylation: By CLOCK, regulating protein stability
• Sumoylation: Modulates transcriptional repression activity

Disease Associations

Alzheimer's Disease (AD)

CRY1 dysfunction is closely linked to AD pathogenesis:

• Circadian Disruption: CRY1 expression is significantly altered in AD brains (inferior temporal gyrus, hippocampus)
• Sleep-Wake Cycle Abnormalities: CRY1 dysfunction contributes to sundowning and fragmented sleep
• Amyloid Regulation: CRY1 may affect [amyloid-beta](/proteins/amyloid-beta) (Abeta) production through [BACE1](/entities/bace1) modulation
• SIRT1 Interaction: CRY1 activity is modulated by SIRT1 deacetylase, linking circadian and metabolic pathways
• [Tau](/proteins/tau) Pathology: CRY1 influences [tau](/proteins/tau) phosphorylation via GSK3beta
• Therapeutic Implications: CRY1-stabilizing compounds being investigated

Parkinson's Disease (PD)

CRY1 plays important roles in PD:

• Dopamine-CRY1 Link: CRY1 regulates tyrosine hydroxylase (TH) and dopamine biosynthesis
• Sleep Disorders: CRY1 alterations contribute to REM sleep behavior disorder (RBD)
• Mitochondrial Function: CRY1 interacts with mitochondrial quality control proteins
• Oxidative Stress: CRY1 deficiency increases vulnerability to oxidative damage
• Levodopa Response: Circadian variations in drug efficacy may involve CRY1

Huntington's Disease (HD)

• Transcriptional Dysregulation: CRY1 expression altered in HD models
• Circadian Phenotypes: HD patients show disrupted circadian rhythms
• Metabolic Effects: CRY1 influences energy metabolism altered in HD

Sleep Disorders

• Delayed Sleep Phase Disorder (DSPD): CRY1 mutations cause familial DSPD
• CRY1 Deletion: Associated with lengthened circadian period
• Non-24-Hour Sleep-Wake Disorder: Seen in blind individuals

Therapeutic Implications

Drug Targets

• CRY1 Stabilizers: Small molecules prolonging CRY1 half-life
• CRY1 Agonists: Enhancing circadian amplitude
• CK1d/e Inhibitors: Slowing CRY1 degradation

Clinical Applications

• AD: CRY1-based chronotherapy for sleep disorders
• PD: Optimizing levodopa timing based on circadian rhythms
• Metabolic Disorders: CRY1 modulators for metabolic syndrome

Chronotherapy

• Timing of Drug Administration: Circadian-optimized treatment delivery
• Light Therapy: CRY1-mediated photoentrainment
• Melatonin Agonists: Downstream CRY1 activation

Genetics

Polymorphisms

• CRY1 Deletion: Lengthened circadian period
• SNPs: Associated with morningness/eveningness preference, sleep duration, metabolic traits, and AD risk

Gene Expression in Disease

• AD Brain: Decreased CRY1 mRNA in prefrontal [cortex](/brain-regions/cortex)
• PD Brain: Altered CRY1 in substantia nigra
• Aging: CRY1 expression declines with age

Interactions

Core Clock Proteins

• PER1/PER2: Heterodimer formation for nuclear translocation
• CLOCK: Transcriptional activator (directly repressed)
• BMAL1: Partner of CLOCK
• FBXL3: E3 ubiquitin ligase targeting CRY1 for degradation

Metabolic Partners

• SIRT1: Deacetylase modulating CRY1 activity
• PGC-1alpha: Mitochondrial biogenesis factor
• PPARgamma: Lipid metabolism regulator

See Also

• [CRY1 Protein](/proteins/cry1-protein)
• [Circadian Clock Pathway](/mechanisms/circadian-clock-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Sleep Dysfunction in Neurodegeneration](/mechanisms/sleep-dysfunction-neurodegeneration)
• [SIRT1 Pathway](/mechanisms/sirt1-pathway)
• [BMAL1 Gene](/proteins/bmal1-protein)

External Links

• [NCBI Gene: CRY1](https://www.ncbi.nlm.nih.gov/gene/1399)
• [UniProt: Q9UQL6](https://www.uniprot.org/uniprot/Q9UQL6)
• [OMIM: 601033](https://www.omim.org/entry/601033)
• [GeneCards: CRY1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRY1)

Background

The study of Cry1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CRY1 Gene discovered through SciDEX knowledge graph analysis: